IDEXX Laboratories Inc

Healthcare · Diagnostics & Research

518.00$ +0.9% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

IDEXX Laboratories Inc (IDXX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 3,442 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IDXX
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	1,500	1,531	1,572	1,637	1,669	1,713	1,469	1,521	1,545	1,537	1,681	1,724	1,751	1,832	1,886	1,961	2,047	2,295	2,327	2,412	2,386	2,437	2,593	2,607	2,640	2,747	2,808	2,871	3,086	3,260	3,354	3,415	3,351	3,293	3,214	3,331	3,387	3,351	3,385	3,442
Current Assets	828	846	879	919	943	972	702	740	704	654	698	712	703	680	721	780	869	1,063	1,098	1,001	938	956	1,090	1,043	1,059	1,101	1,149	1,179	1,384	1,495	1,502	1,529	1,434	1,400	1,318	1,362	1,407	1,340	1,454	1,509
Cash	150	155	160	166	169	188	159	175	147	124	117	111	104	90	81	105	176	384	351	232	145	144	205	114	99	113	111	133	332	454	397	402	309	288	164	165	208	180	201	197
Cash & Short-Term Investments	391	392	400	423	454	472	159	175	147	124	117	111	104	90	81	105	176	384	351	232	145	144	205	114	99	113	111	133	332	454	397	402	309	288	164	165	208	180	201	197
Receivables	218	232	246	266	249	270	265	272	296	259	307	322	304	307	334	355	382	375	423	427	425	426	466	473	453	491	520	532	522	530	578	608	587	474	604	663	715	693	697	742
Inventory	168	158	172	170	177	164	179	176	180	173	189	197	205	195	212	229	218	210	226	241	258	269	302	333	355	368	391	395	394	380	391	380	390	382	396	393	392	378	382	392
Property, Plant & Equipment	350	357	361	365	368	379	384	394	410	437	449	470	497	534	546	551	548	555	544	550	573	588	593	594	612	649	665	683	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	181	178	181	197	200	200	201	196	216	214	215	215	212	240	233	235	238	243	243	354	355	359	361	356	355	362	363	364	362	366	409	408	412	405	407	414	414	414	412	411
Intangible Assets	48	46	46	46	45	44	42	39	42	42	39	38	36	58	58	56	53	53	54	97	95	99	105	101	100	98	94	91	87	85	115	111	107	112	107	104	115	110	105	98
Total Liabilities	1,445	1,639	1,646	1,723	1,718	1,767	1,518	1,562	1,546	1,547	1,629	1,553	1,549	1,655	1,778	1,687	1,606	1,662	1,624	1,664	1,630	1,747	1,953	2,150	2,164	2,138	1,967	1,777	1,789	1,775	1,785	1,835	1,733	1,698	1,766	1,872	1,826	1,745	1,829	1,830
Current Liabilities	760	935	936	1,001	997	1,005	729	774	760	770	690	619	627	725	846	541	527	583	621	652	634	764	971	1,167	1,190	1,236	1,066	884	970	952	957	1,117	1,009	1,068	1,136	1,224	1,252	1,149	1,300	1,288
Short-Term Debt	488	611	671	704	686	655	408	437	415	399	361	267	244	304	502	138	67	68	143	144	95	168	421	631	652	674	526	359	420	345	344	440	370	168	513	680	632	500	707	696
Accounts Payable	44	60	62	59	61	67	70	68	65	70	70	68	76	72	74	74	72	75	87	93	87	116	121	127	110	110	118	108	113	111	117	117	111	114	120	117	122	110	130	129
Long-Term Debt	599	593	595	601	604	606	609	603	602	601	699	701	697	699	697	900	853	858	779	780	778	775	773	768	761	694	696	697	619	623	621	525	525	450	450	450	375	375	300	300
Shareholders' Equity	55	-108	-74	-86	-49	-54	-49	-41	-1.6	-9.5	52	171	202	177	108	273	441	632	703	747	755	690	640	457	476	609	841	1,094	1,297	1,485	1,569	1,580	1,618	1,595	1,448	1,459	1,561	1,605	1,556	1,613
Retained Earnings	488	540	609	695	765	804	880	989	1,082	1,168	1,271	1,396	1,505	1,596	1,706	1,855	2,001	2,176	2,380	2,582	2,758	2,920	3,114	3,246	3,427	3,600	3,814	4,038	4,250	4,445	4,680	4,883	5,116	5,332	5,575	5,869	6,144	6,392	6,670	7,009
Shares Outstanding	91	91	90	90	89	89	89	89	88	88	88	88	88	87	87	86	87	87	87	87	87	86	86	85	84	84	84	84	84	84	84	83	83	83	82	81	81	81	81	81

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings